Receive the latest alerts via email

New stock valuation – Alexion Pharmaceuticals Inc(ALXN)

Alexion Pharmaceuticals Inc (NASDAQ:ALXN) (fair value) Par 2%

Website https://alexion.com/
Sector Healthcare
Industry Biotechnology
Fiscal Year End Dec 31, 2020
Market Cap $34,140,194,816
Beta 1.34239
Average Volume $2,545,568
Last Dividend 0%
Price on Feb 8, 2021 $155.29
Autochartist™ Valuation $152.38
Conclusion
2%
(fair value)
Download Report
Total
0
Shares
Previous Post

New stock valuation – Estee Lauder Companies Inc(EL)

Next Post

New stock valuation – Exelon Corp(EXC)

Related Posts